{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-043577","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2026-04-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.791095+00:00","generated_at":"2026-05-15T06:31:00.646383+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Jon Kuwahara resigns from Emmaus Life Sciences board","bullets":["Director Jon Kuwahara resigned from the board of Emmaus Life Sciences on April 13, 2026, effective April 15, 2026.","Willis Lee remains Chairman and Chief Executive Officer of Emmaus Life Sciences.","Emmaus Life Sciences has no securities registered under Section 12(b) of the Exchange Act and no trading symbol."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-043577","json":"https://secwatch.observer/filing/0001213900-26-043577.json","markdown":"https://secwatch.observer/filing/0001213900-26-043577.md","text":"https://secwatch.observer/filing/0001213900-26-043577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390026043577/0001213900-26-043577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390026043577/ea0286215-8k_emmaus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-15T06:31:00.646383+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}